Evidence map›Paper›PMID 40506732›Full record

ArticleCritical care (London, England)2025

Invasive group A streptococcus infections in the intensive care unit: an unsupervised cluster analysis of a multicentric retrospective cohort.

Tomas Urbina, Lilith Faucheux, Jean-Rémi Lavillegrand, Julien Massol, Marie Lecronier, Quentin de Roux, Matthieu Turpin, William Menard, Melchior Gautier, Guilene Barnaud and 11 more

Abstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Tomas UrbinaService de Médecine Intensive-Réanimation, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, AP-HP, Paris, France. tomas.urbina@aphp.fr.
Lilith FaucheuxService de Médecine Intensive-Réanimation, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, AP-HP, Paris, France.
Jean-Rémi LavillegrandService de Médecine Intensive-Réanimation, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
Julien MassolService de Médecine Intensive-Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Marie LecronierService de Médecine Intensive-Réanimation (Département « R3S »), Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Quentin de RouxService d'Anesthésie-Réanimation et Médecine Péri-Opératoire, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Créteil, France.
Matthieu TurpinService de Médecine Intensive-Réanimation, Hôpital Tenon, Assistance Publique-Hôpitaux de Paris, Paris, France.
William MenardMedical and Surgical Intensive Care Unit, GHU Paris-Saclay, Assistance Publique Hôpitaux de Paris, University Hospital Ambroise Paré, Boulogne-Billancourt, France.
Melchior GautierService de Médecine Intensive-Réanimation, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris, Paris, France.
Guilene BarnaudAP-HP, Hôpital Louis Mourier, Service de Microbiologie et Hygiène, Université Paris Cité, Colombes, France.
Damien RouxUniversité Paris Cité, AP-HP, Hôpital Louis Mourier, DMU ESPRIT, Médecine intensive réanimation, INSERM, INEM U1151, Paris, France.
Charles-Edouard LuytService de Médecine Intensive-Réanimation, Institut de Cardiologie, Groupe Hospitalier Pitié-Salpêtrière, Assistance Publique Hôpitaux de Paris, Paris, France.
Antoine Vieillard-BaronMedical and Surgical Intensive Care Unit, GHU Paris-Saclay, Assistance Publique Hôpitaux de Paris, University Hospital Ambroise Paré, Boulogne-Billancourt, France.
Guillaume VoiriotGRC SoLID; Assistance Publique - Hôpitaux de Paris, Hôpital Tenon, DMU APPROCHES, Service de Médecine Intensive Réanimation, CRSA UMRS_938 INSERM Team 5PMed, Sorbonne Université, Paris, France.
Nicolas MongardonService d'Anesthésie-Réanimation et Médecine Péri-Opératoire, Assistance Publique-Hôpitaux de Paris, Hôpitaux Universitaires Henri Mondor, Créteil, France.
Maxens DecaveleService de Médecine Intensive-Réanimation (Département « R3S »), Hôpital Pitié-Salpêtrière, Assistance Publique-Hôpitaux de Paris, Paris, France.
Frédéric PèneService de Médecine Intensive-Réanimation, Hôpital Cochin, Assistance Publique-Hôpitaux de Paris, Paris, France.
Jérémie JoffreService de Médecine Intensive-Réanimation, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, AP-HP, Paris, France.
Hafid Ait-OufellaService de Médecine Intensive-Réanimation, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
Nicolas de ProstService de Médecine Intensive-Réanimation, Hôpital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
Eric MauryService de Médecine Intensive-Réanimation, Hôpital Saint-Antoine, Assistance Publique-Hôpitaux de Paris, AP-HP, Paris, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundInvasive group A streptococcus (iGAS) infection incidence is rising. These infections have been studied as a whole but can be associated with critical illness in a population with a wide array of underlying conditions, sites of infection and clinical presentations. Using an unsupervised clustering approach, we aimed to identify specific clinical phenotypes regarding presentation, management and outcome.

methodsThis was a retrospective multicentric study including all patients admitted to one of 9 ICUs of Paris University Hospitals for an iGAS infection between 01/03/2018 and 01/08/2023. iGAS infection was defined as GAS growth in any microbiological sample from a sterile site. Patients were grouped according to a clustering algorithm (k-prototypes) using a comprehensive set of clinical and biological variables available upon ICU admission. Clusters were described and clinical presentation, management and outcome were compared.

results148 patients were included. According to the Silhouette criterion, patients were grouped in 3 clusters, and 7 patients remained unclassified. Cluster 1 (n = 73) comprised a greater proportion of less severely-ill female patients with painful skin and soft tissue infections, a quarter of whom had taken non-steroidal anti-inflammatory drugs. Cluster 2 (n = 42) was characterized by a high rate of respiratory infections with frequent viral co-infections. Cluster 3 (n = 26) included mostly socially deprived patients with high rates of chronic alcohol consumption and psychiatric illness, with severe organ dysfunction related to otherwise pauci-symptomatic skin and soft tissue infections. There was no significant difference in time to source control across clusters (0 [0-0] vs 0 [0-0] vs 0 [0-1] days, p = 0.12). Patients included in cluster 2 less frequently received antitoxin antibiotics than patients from clusters 1 and 3 (79% vs 45% vs 69%, p < 0.001) and tended to more frequently require ECMO support (3% vs 12% vs 0%, p = 0.07), while those from cluster 1 were less likely to receive invasive mechanical ventilation (48% vs 74% vs 77%, p = 0.005). There was no difference in ICU-mortality between clusters (19% vs 29% vs 31%, p = 0.32).

conclusionsBased on simple and readily available clinical admission characteristics of critically ill patients with iGAS, unsupervised clustering analysis identified three specific patient populations that differed regarding ICU management. Whether tailoring management would affect outcome warrants further research.

Indexed as

Streptococcal InfectionsAdultAgedCluster AnalysisCohort StudiesFemaleFranceHumansIntensive Care UnitsMaleMiddle AgedParisRetrospective StudiesStreptococcus pyogenesCritically-illGroup A streptococcusIntensive care unitNecrotizing soft-tissue infectionSocial deprivationToxic shock

Identifiers

PMID40506732
PMCPMC12164110

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.